We develop, produce and market active ingredients for pharmaceutical and biotechnological industries to more than 70 countries and 3,000 clients.
Human
APIS
Experts in developing
high quality pharmaceutical active ingredients
Our wide experience backs us up
Contact us and we will provide you with details of our extensive product portfolio.
Strategic
APIS
- MINOCYCLINE HCl – Antibiotic
- LYMECYCLINE – Antibiotic
- TETRACYCLINE HCl – Antibiotic
- RIVAROXABAN – Anticoagulant
- CLOMIPHENE CITRATE – Fertility
- OXYTETRACYCLINE Ca – Antibiotic
- CLOBUTINOL HCl – Antitussive
- ANASTROZOLE – Oncology
- BISOPROLOL FUMARATE – Antihypertensive
- ENOXAPARINE SODIUM – Anticoagulant
- PIPERACILLIN + TAZOBACTAM – Antibiotic
- TRIMEBUTINE MALEATE – Antiemetic
- VALSARTAN – Antihypertensive
- GABAPENTIN – Antiepileptics
- IMATINIB MESYLATE – Oncology
- COLISTIMETHATE SODIUM – Antibiotic
- QUETIAPINE FUMARATE – Antipsychotic
- MUPIROCIN Ca – Antibiotic
Research
& Development
API | USO | LANZAMIENTO GENÉRICO ESPERADO EN EUROPA |
|---|---|---|
| APIXABAN | ANTICOAGULANT | MAY 26 |
| BOSUTINIB | ONCOLOGY | JANUARY - 28 |
| COBICISTAT | ANTIRETROVIRAL | SEPTEMBER - 24 |
| DOLUTEGAVIR SODIUM | ANTIRETROVIRAL | JANUARY - 29 |
| ENZALUTAMIDE | ONCOLOGY | DECEMBER - 24 |
| MIRABEGRON | UROLOGY | JUNE - 28 |
| SELEXIPAG | PULMONAR HYPERTENSION | APRIL - 29 |
| TICAGRELOR | ANTIPLATELET AGENT | OCTOBER - 27 |
| UMECLIDINIUM BROMIDE | COPD | NOVEMBER - 26 |
| VORTIOXETINE | ANTIDEPRESSANT | ABRIL - 27 |
Items covered by valid patents are not offered or supplied for commercial use.
Products under patent are available for R&D use only.
Other products developed
& manufactured under exclusive basis
Specialized products with studies
and available clinical data
If you can´t find the product you are looking for,
or you are interested in developing a new product,
please contact us.
+34 91 344 68 90
info@suanfarma.com